1% to 1%):
Descriptions Aripiprazole is used alone or together with other medicines to
If any of these Drug details You’ll find key information about Abilify below
Overdose Resources and support Q&A Abilify basics If you have certain
It may be used in combination with an
Dosage forms: TAB: 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg schizophrenia [13-17 yo] Dose: 10 mg PO qd; Start: 2 mg PO qd x2 days, then 5 mg PO qd x2 days, then incr
Adults: Efficacy was established in four 4-6 week trials and one maintenance trial in patients with schizophrenia ; Adolescents (ages 13-17): Efficacy was established in one 6-week trial in patients with schizophrenia ; Acute treatment of manic
Adults: Efficacy was established in four 4-6 week trials and one maintenance trial in patients with schizophrenia ; Adolescents (ages 13-17): Efficacy was established in one 6-week trial in patients with schizophrenia ; Acute treatment of manic
All causes of macrocytic anemia were excluded as well as most common causes for hemolytic anemia: The patient did not present any medical risk factors, rheumatologic, or neoplastic causes; and common drugs were excluded
More serious side effects, although rare, may include suicidal thoughts, neuroleptic malignant syndrome (a potentially life-threatening neurological disorder), and allergic reactions
In this article, you’ll find additional information about Abilify’s dosage and details on how to take the drug
Aripiprazole is in a class of medications called atypical antipsychotics
Anemia, Hemolytic / chemically induced* Antidepressive Agents / administration & dosage Antidepressive Agents / adverse effects* Antipsychotic Agents / administration & dosage Antipsychotic Agents / adverse effects* Aripiprazole / administration & dosage There have been reports of babies exposed to aripiprazole during late pregnancy who had withdrawal symptoms after birth
Sometimes these have been deadly
Patients should be periodically reassessed to determine the need for maintenance treatment
Since Abilify Maintena Aripiprazol (handelsnamn: Abilify) är ett neuroleptikum, ett atypiskt antipsykotikum, som vid introduktionen kallades för dopaminstabiliserare [1] och har beskrivits som prototypen för en "tredje" generations antipsykotika